Ra Session II Net Worth & Insider Trades

Ra Session II - President and CEO, Taysha Gene Therapies, Inc

As of February 25, 2022

What is Ra Session II's Net Worth?

The current estimated net worth of Taysha Gene Therapies, Inc's President and CEO, Ra Session II, is estimated to be about $20.68M . Ra Session II owns about 9,332,010 units of Taysha Gene Therapies, Inc common stock. In the last year at Taysha Gene Therapies, Inc, Ra Session II has sold an estimated value of $0 worth.

What is Ra Session II's Past Insider Trading?

Ra Session II's largest purchase order was 42,518 units , worth over $529.1K on December 8, 2021. In total, Ra Session II has made about 3 transactions over a year of their time at Taysha Gene Therapies, Inc. Ra Session II usually trades in January, February and December, with the busiest year in 2021.

RA Session II

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ra Session II's' Mailing Address?

  • Mailing address is C/o Avexis, Inc. 2275 Half Day Road, Suite 200 Bannockburn IL 60015 IL

What are Taysha Gene Therapies, Inc's Past Insider Trades?

Taysha Gene Therapies, Inc's most recent insider trade came on November 2, 2022 by Paul Manning who bought 1,500,000 units worth $3M . In the last year, insiders at Taysha Gene Therapies, Inc have sold an estimated value of $2.69M and bought an estimated value of $5.76M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are Paul Manning, Director,  Suyash Prasad, CMO and Head R&D,  and Kamran Alam, Chief Financial Officer .

Taysha Gene Therapies, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1